Company intelligence / Profile preview

iQur

London, United Kingdomiqur.com ↗
Ownership
Private
Development stage
Other
01

Overview

No clinical results reported; programs remain in preclinical or pending stages.

Therapeutic areas
Infectious Diseases
Modalities
Prophylactic vaccine
Industry
Biotech
02

Drug pipeline

1 asset

AX-LAH3 MAb

Discontinued
03

Partnerships

Edward Jenner Institute for Vaccine ResearchUniversity of Southampton Liver groupUniversity of Nottingham

Beyond the preview

Go deeper on iQur.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iQur.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call